Exact Mass: 354.1807306

Exact Mass Matches: 354.1807306

Found 500 metabolites which its exact mass value is equals to given mass value 354.1807306, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Vincamine

Methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate

C21H26N2O3 (354.19433260000005)

Vincamine is a vinca alkaloid, an alkaloid ester, an organic heteropentacyclic compound, a methyl ester and a hemiaminal. It has a role as an antihypertensive agent, a vasodilator agent and a metabolite. It is functionally related to an eburnamenine. Vincamine is a monoterpenoid indole alkaloid obtained from the leaves of *Vinca minor* with a vasodilatory property. Studies indicate that vincamine increases the regional cerebral blood flow. Vincamine is a natural product found in Vinca difformis, Vinca major, and other organisms with data available. A major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders. Vincamine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1617-90-9 (retrieved 2024-07-01) (CAS RN: 1617-90-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2]. Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2].

Yohimbine

(1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2,3:3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester hydrochloride

C21H26N2O3 (354.19433260000005)

Yohimbine is an indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina. It has a role as an alpha-adrenergic antagonist, a serotonergic antagonist and a dopamine receptor D2 antagonist. It is functionally related to a yohimbic acid. A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. Yohimbine is an indole alkaloid derived from the bark of the Central African yohimbe tree (Pausinystalia yohimbe) that is widely used as therapy for erectile dysfunction. Yohimbine use has been associated with occasional severe adverse events, but has not been linked to serum enzyme elevations or clinically apparent acute liver injury. Yohimbine is a natural product found in Rauvolfia yunnanensis, Tabernaemontana corymbosa, and other organisms with data available. A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine Hydrochloride (active moiety of) ... View More ... Yohimbine is only found in individuals that have used or taken this drug. It is a plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. [PubChem]Yohimbine is a pre-synaptic alpha 2-adrenergic blocking agent. The exact mechanism for its use in impotence has not been fully elucidated. However, yohimbine may exert its beneficial effect on erectile ability through blockade of central alpha 2-adrenergic receptors producing an increase in sympathetic drive secondary to an increase in norepinephrine release and in firing rate of cells in the brain noradrenergic nuclei. Yohimbine-mediated norepinephrine release at the level of the corporeal tissues may also be involved. In addition, beneficial effects may involve other neurotransmitters such as dopamine and serotonin and cholinergic receptors. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction An indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina. C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents D001697 - Biomedical and Dental Materials > D003764 - Dental Materials Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2] Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]

CHEMBL441356

(S)-N-Methylcanadine

C21H24NO4+ (354.17052440000003)

Tephrowatsin A

C22H26O4 (354.18309960000005)

A hydroxyflavan that is (2S)-flavan substituted by hydroxy group at position 4, methoxy groups at positions 5 and 7 and a prenyl group at position 8 respectively.

stemmadenine

C21H26N2O3 (354.19433260000005)

Sultopride

5-(Ethanesulphonyl)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzene-1-carboximidic acid

C17H26N2O4S (354.16131960000007)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Same as: D08549

Minovincinine

C21H26N2O3 (354.19433260000005)

17-O-acetylnorajmaline

C21H26N2O3 (354.19433260000005)

An indole alkaloid obtained by formal acetylation of the 17-hydroxy group of norajmaline.

3,6-Dimethoxyestra-1,3,5(10),6,8-pentaene-17beta-carboxylic acid methyl ester

C22H26O4 (354.18309960000005)

N-demethylvindolidine

methyl (1S,10R,12R,19S)-12-ethyl-10-hydroxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C21H26N2O3 (354.19433260000005)

Corynanthin

Methyl 18-hydroxy-3,13- diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa- 2(10),4,6,8-tetraene-19-carboxylate

C21H26N2O3 (354.19433260000005)

Methyl 17-hydroxy-20xi-yohimban-16-carboxylate is a yohimban alkaloid, a methyl ester and an organic heteropentacyclic compound. Methyl 17-hydroxy-20xi-yohimban-16-carboxylate is a natural product found in Aspidosperma oblongum, Aspidosperma ramiflorum, and other organisms with data available. D001697 - Biomedical and Dental Materials > D003764 - Dental Materials

Valganciclovir

2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate

C14H22N6O5 (354.1651602)

Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

Acetylsalvipisone

7-Methyl-8-(4-methylpent-4-en-1-yl)-1,4-dioxo-3-(propan-2-yl)-1,4-dihydronaphthalen-2-yl acetic acid

C22H26O4 (354.18309960000005)

Acetylsalvipisone is found in alcoholic beverages. Acetylsalvipisone is a constituent of Salvia sclarea (clary sage)

Propofol glucuronide

(2S,3S,4S,5R,6S)-6-[2,6-bis(propan-2-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C18H26O7 (354.16784459999997)

Propofol glucuronide is a metabolite of propofol. Propofol is a short-acting, intravenously administered hypnotic agent. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol is also commonly used in veterinary medicine. Propofol is approved for use in more than 50 countries, and generic versions are available. (Wikipedia)

1-dodecanoyl-glycero-3-phosphate

[(2R)-3-(dodecanoyloxy)-2-hydroxypropoxy]phosphonic acid

C15H31O7P (354.1807306)

1-dodecanoyl-glycero-3-phosphate is also known as LPA(12:0/0:0) or (2R)-2-Hydroxy-3-(phosphonooxy)propyl laurate. 1-dodecanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-dodecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

LysoPA(i-12:0/0:0)

{2-hydroxy-3-[(10-methylundecanoyl)oxy]propoxy}phosphonic acid

C15H31O7P (354.1807306)

LysoPA(i-12:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-12:0/0:0), in particular, consists of one chain of isododecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

3-(4-(2-Dimethylamino-1-methylethoxy)phenyl)-1H-pyrazolo(3,4-b)pyridine-1-acetic acid

2-[3-(4-{[1-(dimethylamino)propan-2-yl]oxy}phenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]acetic acid

C19H22N4O3 (354.1691822)

(4R,6S)-6-[(E)-2-[2-(4-Fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one

C22H23FO3 (354.16311399999995)

Corynanthine

Methyl 18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylic acid

C21H26N2O3 (354.19433260000005)

Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate

Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid

C17H26N2O6 (354.1790776)

Hydroxybenzylpindolol

4-(2-{[2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino}-2-methylpropyl)phenol

C21H26N2O3 (354.19433260000005)

Iclaprim

5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4-diamine

C19H22N4O3 (354.1691822)

Isovincamine

Methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylic acid

C21H26N2O3 (354.19433260000005)

Bronica

7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid

C22H26O4 (354.18309960000005)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents R - Respiratory system > R03 - Drugs for obstructive airway diseases D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].

Valganciclovir, (S)-

3-Hydroxy-2-[(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)methoxy]propyl 2-amino-3-methylbutanoic acid

C14H22N6O5 (354.1651602)

7-(2,5-Dihydroxy-3,4,6-trimethylphenyl)-7-phenylhept-6-enoic acid

C22H26O4 (354.18309960000005)

17-O-acetylnorajmaline

13-ethyl-14-hydroxy-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-yl acetate

C21H26N2O3 (354.19433260000005)

17-o-acetylnorajmaline is a member of the class of compounds known as ajmaline-sarpagine alkaloids. Ajmaline-sarpagine alkaloids are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. 17-o-acetylnorajmaline is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 17-o-acetylnorajmaline can be found in a number of food items such as black chokeberry, sapodilla, common pea, and cardamom, which makes 17-o-acetylnorajmaline a potential biomarker for the consumption of these food products.

19(R)-Methoxytubotaiwine

C21H26N2O3 (354.19433260000005)

Kopsinoline

C21H26N2O3 (354.19433260000005)

Annotation level-1

(1R,2S,4S,7Z,8R,9S)-7-ethylidene-1-methoxy-5-methylspiro[11-oxa-5-azatricyclo[6.3.1.0^{4,9]dodecane-2,3-indole]-2-one

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several species of Tabernaemontana.

(-)-Cyclogalgravin

C22H26O4 (354.18309960000005)

Pandoline

(+)-7alpha-Hydroxy pseudovincadifformine

C21H26N2O3 (354.19433260000005)

Taxamairin E

C22H26O4 (354.18309960000005)

NSC306218

C21H26N2O3 (354.19433260000005)

Sitsirikine

methyl (2R)-2-[(2S,3R,12bS)-3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate

C21H26N2O3 (354.19433260000005)

methyl (2R)-2-[(2S,3R,12bS)-3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate is a natural product found in Alstonia angustifolia, Rauvolfia caffra, and Strychnos pungens with data available.

Pelirine

10-Methoxyepiaffinine

C21H26N2O3 (354.19433260000005)

Schizophylline

C21H26N2O3 (354.19433260000005)

Haplocidine

C21H26N2O3 (354.19433260000005)

DS-000163

C21H26N2O3 (354.19433260000005)

Leptin H

C18H26O7 (354.16784459999997)

Coronaridine pseudoindoxyl

C21H26N2O3 (354.19433260000005)

(+)-Bornyl piperate

C22H26O4 (354.18309960000005)

11-Hydroxycoronaridine

C21H26N2O3 (354.19433260000005)

12-Methoxytubotaiwine

C21H26N2O3 (354.19433260000005)

Tacamine

C21H26N2O3 (354.19433260000005)

3-Hydroxycoronaridine

19-Hydroxycoronaridine

C21H26N2O3 (354.19433260000005)

coronaridine hydroxyindolenine

C21H26N2O3 (354.19433260000005)

3-Epivobasinol

C21H26N2O3 (354.19433260000005)

10-Hydroxycoronaridine

C21H26N2O3 (354.19433260000005)

An organic heteropentacyclic compound that is coronaridine in which the hydrogen of the indole moiety that is para- to the indole nitrogen has been replaced by a hydroxy group.

15beta-Hydroxyvincadifformine

(+)-6beta-Hydroxyvincadifformine

C21H26N2O3 (354.19433260000005)

(-)-12-Hydroxyvincadifformine

C21H26N2O3 (354.19433260000005)

Lundurine C

C21H26N2O3 (354.19433260000005)

N-Methylsinactine

(S)-cis-N-Methylsinactine

C21H24NO4 (354.17052440000003)

Cathafoline N(4)-oxide

C21H26N2O3 (354.19433260000005)

N-Methylpapaverine

C21H24NO4+ (354.17052440000003)

N-Methylnantenine

C21H24NO4+ (354.17052440000003)

vincophylline

C21H26N2O3 (354.19433260000005)

N-Methylcanadine

N-Methyl-(-)-alpha-canadinium

C21H24NO4 (354.17052440000003)

3-epi-a-Yohimbine

3-epi-alpha-yohimbine

C21H26N2O3 (354.19433260000005)

N-Methylcanadine hydroxide

C21H24NO4 (354.17052440000003)

N-Methyl canadine

C21H24NO4 (354.17052440000003)

N-Methyleschscholtzidine

C21H24NO4+ (354.17052440000003)

Ld 91

19beta-Hydroxykopsinine

C21H26N2O3 (354.19433260000005)

19(S)-Methoxytubotaiwine

(+)-19(S)-Methoxytubotaiwine

C21H26N2O3 (354.19433260000005)

Gendenafil

C19H22N4O3 (354.1691822)

MLS000859795

C21H26N2O3 (354.19433260000005)

MLS000833546

C21H26N2O3 (354.19433260000005)

19S-Methoxytubotaiwine

C21H26N2O3 (354.19433260000005)

Annotation level-1

Maculalactone

C25H22O2 (354.1619712)

11-Methoxylimatinine

C21H26N2O3 (354.19433260000005)

3beta-acetoxyl-8beta,10beta-dihydroxy-6beta-methoxyeremophilenolide

C18H26O7 (354.16784459999997)

10-methoxy-2,7-dihydropleiocarpamine

C21H26N2O3 (354.19433260000005)

(+/-)-N-formyltortuosamine|N-Formyl-(??)-(??)-Tortuosamine|N-Formyltortuosamin|N-formyltortuosamine|N-{2-[6-(3,4-dimethoxy-phenyl)-5,6,7,8-tetrahydro-quinolin-6-yl]-ethyl}-N-methyl-formamide

C21H26N2O3 (354.19433260000005)

10-Hydroxy-17-O-methylakagerine

C21H26N2O3 (354.19433260000005)

(-)-Raucubainine

C21H26N2O3 (354.19433260000005)

(+/-)-19-hydroxycoronaridine|(-)-19S-heynanine

C21H26N2O3 (354.19433260000005)

Hydroxykopsinine I

C21H26N2O3 (354.19433260000005)

C21H26N2O3

C21H26N2O3 (354.19433260000005)

6beta-acetoxy-7beta-hydroxy-1beta-methoxy-1alpha,8alpha-oxido-10beta,11betaH-eremophilan-12,8-olide

C18H26O7 (354.16784459999997)

acetoxyjatropholone

C22H26O4 (354.18309960000005)

16-hydroxymethyl-4,5-seco-condyfol-14(19)-ene-16-carboxylic acid methyl ester|Precondylocarpin

C21H26N2O3 (354.19433260000005)

Corynanthine

Yohimban-16-carboxylicacid, 17-hydroxy-, methyl ester, (16b,17a)-

C21H26N2O3 (354.19433260000005)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.574 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.571 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.566 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.567

Iboxyphylline

C21H26N2O3 (354.19433260000005)

15alpha-hydroxykopsinine

C21H26N2O3 (354.19433260000005)

19,20-dihydropolyneuridine

C21H26N2O3 (354.19433260000005)

negombin D

C20H31ClO3 (354.1961606)

3alpha-propionyloxy-5beta-(4-hydroxytigloyloxy)-7-hydroxycarvotacetone|3alpha-propionyloxy-5beta-<4-hydroxytigloyloxy>-7-hydroxycarvotacetone

C18H26O7 (354.16784459999997)

Acetyllimbinol

C22H26O4 (354.18309960000005)

catharinensine

C21H26N2O3 (354.19433260000005)

Cannabinolic acid

C22H26O4 (354.18309960000005)

19-epi-23-hydroxyspermostrychnine

C21H26N2O3 (354.19433260000005)

N-Desacetyl-18-acetoxyisoretuline

C21H26N2O3 (354.19433260000005)

4-O-beta-D-Glucopyranoside-4-Hydroxy-3-(3-methyl-2-butenyl)benzenemethanol

C18H26O7 (354.16784459999997)

C22H26O4

C22H26O4 (354.18309960000005)

deformylcorymine

C21H26N2O3 (354.19433260000005)

11-hydroxyvincadifformine

C21H26N2O3 (354.19433260000005)

Ibogamine-18-carboxylicacid, 13-hydroxy-, methyl ester (9CI)

C21H26N2O3 (354.19433260000005)

tabernaemontanine

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several species of Tabernaemontana.

1-O-beta-Glucopyranoside-2-Methyl-6-(3-methyl-2-butenyl)-1,4-benzenediol,9CI

C18H26O7 (354.16784459999997)

17-hydroxy-19,20-dihydro-sarpagane-16-carboxylic acid methyl ester|19, 20-Dihydropolyneuridine|Dihydroakuammidin

C21H26N2O3 (354.19433260000005)

10-Hydroxy-17-O-methylkribine

C21H26N2O3 (354.19433260000005)

(ent-5alpha,15()-16-Chloro-3,15-dihydroxy-3-erythroxylen-2-one

C20H31ClO3 (354.1961606)

(1beta,5alpha,7beta,8beta)-8-(acetyloxy)-5-hydroperoxy-1-hydroxycostic acid methyl ester|methyl rel-(2R,3R,4aS,5R,8aR)-3-(acetyloxy)decahydro-8a-hydroperoxy-5-hydroxy-4a-methyl-a,8-bis(methylene)naphthalene-2-acetate

(1beta,5alpha,7beta,8beta)-8-(acetyloxy)-5-hydroperoxy-1-hydroxycostic acid methyl ester|methyl rel-(2R,3R,4aS,5R,8aR)-3-(acetyloxy)decahydro-8a-hydroperoxy-5-hydroxy-4a-methyl-a,8-bis(methylene)naphthalene-2-acetate

C18H26O7 (354.16784459999997)

(15S)-hydroxy-14,15-dihydrovindolinine

C21H26N2O3 (354.19433260000005)

(17alpha)-17-hydroxykopsinine|(2alpha,3beta,4alpha,5alpha,12R,19alpha)-4-hydroxy-2,21-cycloaspidospermidine-3-carboxylic acid|17alpha-hydroxykopsinine|kopsiloscine G

C21H26N2O3 (354.19433260000005)

3,5-Ethano-3H-pyrrolo[2,3-d]carbazole-6-carboxylic acid, 4-ethyl-1,2,3a,4,5,7-hexahydro-11-methoxy-, methyl ester, stereoisomer

C21H26N2O3 (354.19433260000005)

kopsinine B

C21H26N2O3 (354.19433260000005)

1-methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H-beta-carbolin-1-yl)cyclopentanol

C21H26N2O3 (354.19433260000005)

17-hydroxy-14,15-dihydrotabersonine

C21H26N2O3 (354.19433260000005)

3-dihydrovirone

C22H26O4 (354.18309960000005)

Isobutyric acid 2-methoxy-4-[3-(isobutyryloxy)-1,2-dihydroxypropyl]phenyl ester

C18H26O7 (354.16784459999997)

17-chloro-13,16beta-dihydroxy-ent-kauran-19-al

C20H31ClO3 (354.1961606)

Kopsinaline

C21H26N2O3 (354.19433260000005)

11,12-dimethoxy-14,15-dihydro-eburnamenin-14-one|Dimethoxy-eburnamonin|Dimethoxyeburnamonine

C21H26N2O3 (354.19433260000005)

(+-)-Vincamin|14-hydroxy-14,15-dihydro-eburnamenine-14-carboxylic acid methyl ester|Vinkamin

C21H26N2O3 (354.19433260000005)

Peroxyferolid

C18H26O7 (354.16784459999997)

flabelliformine|methyl (3E,4S)-3-ethylidene-4-{1-[3-(methoxymethyl)-1H-indol-2-yl]ethenyl}piperidine-1-carboxylate

C21H26N2O3 (354.19433260000005)

Strictaminolamine

C21H26N2O3 (354.19433260000005)

4alpha,10beta-dihydroxy-3alpha-methoxy-8alpha-acetoxy-11betaH-guai-1-en-12,6alpha-olide

C18H26O7 (354.16784459999997)

3-Iso-19-epi-ajnalicin

C21H26N2O3 (354.19433260000005)

SCHEMBL17655660

C22H26O4 (354.18309960000005)

SCHEMBL17725922

C22H26O4 (354.18309960000005)

ent-5alpha,16-chloro-2-oxodolabr-3-ene-3,15xi-diol

C20H31ClO3 (354.1961606)

20-Epiervatamin|4-ethyl-2-methyl-6-oxo-2,3,4,4a,5,6,7,12-octahydro-1H-pyrido[3,4:4,5]cyclohepta[1,2-b]indole-12a-carboxylic acid methyl ester

C21H26N2O3 (354.19433260000005)

(19S)-1-acetyl-17,19-epoxy-curan-3-ol|Acetylisostrychnosplendine|N(a)-Acetyl-isostrychnosplendin|N-acetyl-isostrychnosplendine

C21H26N2O3 (354.19433260000005)

Halitunal

C22H26O4 (354.18309960000005)

12-hydroxy-21,22-dihydro-12,24-seco-strychnidin-10-one|Protostrychnin|Protostrychnine

C21H26N2O3 (354.19433260000005)

4-acetylpyrenophorol

C18H26O7 (354.16784459999997)

rhazimanine

C21H26N2O3 (354.19433260000005)

Aspidoalbidine, 1-formyl-17-methoxy-

C21H26N2O3 (354.19433260000005)

Gln Ala His

C14H22N6O5 (354.1651602)

His Gln Ala

C14H22N6O5 (354.1651602)

Ala Gln His

C14H22N6O5 (354.1651602)

His Ala Gln

C14H22N6O5 (354.1651602)

Ala His Gln

C14H22N6O5 (354.1651602)

2,3-Dimethoxy-7-methyl-9,10-methylenedioxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine-7-ium

C21H24NO4+ (354.17052440000003)

Rauwolscine

(1S,2S,4aS,13bS,14aS)-Methyl 2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2,3:3,4]pyrido[1,2-b]isoquinoline-1-carboxylate

C21H26N2O3 (354.19433260000005)

Rauwolscine is a methyl 17-hydroxy-20xi-yohimban-16-carboxylate. Rauwolscine is a natural product found in Alstonia constricta, Corynanthe johimbe, and other organisms with data available. A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.457 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.455 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.451 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.448 Rauwolscine is a selective α2-adrenoceptor antagonist that inhibits tumor growth and induces apoptosis[1].

Alloyohimbin

(1r,2s,4as,13bs,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2,3:3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester, AldrichCPR

C21H26N2O3 (354.19433260000005)

Allo-yohimbine is a methyl 17-hydroxy-20xi-yohimban-16-carboxylate. allo-Yohimbine is a natural product found in Corynanthe johimbe, Alstonia yunnanensis, and other organisms with data available.

Humantenine

(1S,2S,4S,7Z,8S,9S)-7-ethylidene-1-methoxy-5-methylspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3-indole]-2-one

C21H26N2O3 (354.19433260000005)

Annotation level-1 Humantenine is a natural product found in Gelsemium elegans and Gelsemium rankinii with data available.

Valganciclovir

C14H22N6O5 (354.1651602)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 2843

Yohimbine

methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate

C21H26N2O3 (354.19433260000005)

G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2282 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.556 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.553 Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2] Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]

methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

NCGC00015878-06!methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

C21H26N2O3 (354.19433260000005)

methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

NCGC00015878-07!methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

C21H26N2O3 (354.19433260000005)

C21H26N2O3_Methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate

NCGC00015878-08_C21H26N2O3_Methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate

C21H26N2O3 (354.19433260000005)

Corynanthin

C21H26N2O3 (354.19433260000005)

Alloyohimbine

allo-Yohimbine

C21H26N2O3 (354.19433260000005)

Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Yohimbinoid alkaloids, Indole alkaloids

Pseudoyohimbine

C21H26N2O3 (354.19433260000005)

Sultopride

C17H26N2O4S (354.16131960000007)

Vincamin

Vincamine

C21H26N2O3 (354.19433260000005)

C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2327 Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2]. Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2].

ITC-12

C17H26N2O4S (354.16131960000007)

2,2,4-Trimethylpentane-1,3-diyl dibenzoate

C22H26O4 (354.18309960000005)

CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10463; ORIGINAL_PRECURSOR_SCAN_NO 10461 CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10565; ORIGINAL_PRECURSOR_SCAN_NO 10560 CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10586; ORIGINAL_PRECURSOR_SCAN_NO 10581

Ala Ala Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C14H22N6O5 (354.1651602)

Ala Ala His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C14H22N6O5 (354.1651602)

Ala Ala Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C16H26N4O5 (354.19031060000003)

Ala Gly Ala His

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C14H22N6O5 (354.1651602)

Ala Gly His Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C14H22N6O5 (354.1651602)

Ala His Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]acetic acid

C14H22N6O5 (354.1651602)

Ala His Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}propanoic acid

C14H22N6O5 (354.1651602)

Ala Pro Ala Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C16H26N4O5 (354.19031060000003)

Ala Pro Pro Ala

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C16H26N4O5 (354.19031060000003)

Gly Ala Ala His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C14H22N6O5 (354.1651602)

Gly Ala His Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C14H22N6O5 (354.1651602)

Gly His Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]propanamido]propanoic acid

C14H22N6O5 (354.1651602)

His Ala Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]propanamido]acetic acid

C14H22N6O5 (354.1651602)

His Ala Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]acetamido}propanoic acid

C14H22N6O5 (354.1651602)

His Gly Ala Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}propanamido]propanoic acid

C14H22N6O5 (354.1651602)

Pro Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H26N4O5 (354.19031060000003)

Pro Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H26N4O5 (354.19031060000003)

Pro Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C16H26N4O5 (354.19031060000003)

propofol glucuronide

C18H26O7 (354.16784459999997)

Gln His Ala

C14H22N6O5 (354.1651602)

PA(12:0/0:0)

1-dodecanoyl-glycero-3-phosphate

C15H31O7P (354.1807306)

Rauhimbin

Yohimban-16-carboxylicacid, 17-hydroxy-, methyl ester, (16b,17a)-

C21H26N2O3 (354.19433260000005)

Cymeval

2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate

C14H22N6O5 (354.1651602)

Acetylsalvipisone

7-methyl-8-(4-methylpent-4-en-1-yl)-1,4-dioxo-3-(propan-2-yl)-1,4-dihydronaphthalen-2-yl acetate

C22H26O4 (354.18309960000005)

LPA 12:0

1-dodecanoyl-glycero-3-phosphate

C15H31O7P (354.1807306)

Alkaloid V3

20R-20-Hydroxy-(-)-vincadifformine

C21H26N2O3 (354.19433260000005)

Liroldine

C20H20F2N4 (354.16559440000003)

4-Acetylbenzo-18-crown 6-Ether

C18H26O7 (354.16784459999997)

1,5-DIPHENYL-4-ETHYL-3-(4-METHOXYPHENYL)-1H-PYRAZOLE

C24H22N2O (354.1732042)

6-[3-[[tert-butyl(dimethyl)silyl]oxymethyl]pyrrolidin-1-yl]-2-fluoropyridine-3-carboxylic acid

C17H27FN2O3Si (354.17748839999996)

(2S,3S)-[2-(3-HYDROXYPYRROLIDIN-1-YL)-1-PHENYLETHYL]METHYLCARBAMICACIDBENZYLESTER

C21H26N2O3 (354.19433260000005)

(R)-2-AMINOHEXANE

C22H26O4 (354.18309960000005)

2-(4-Tert-Butylphenyl)-5-(4-Biphenyl)-1,3,4-Oxadiazole

C24H22N2O (354.1732042)

N-(hydroxymethyl)prop-2-enamide,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,prop-2-enenitrile

C17H26N2O6 (354.1790776)

(Triphenylen-2-yl)boronic acid pinacol ester

C24H23BO2 (354.17910079999996)

BENZYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YLCARBAMATE

C19H23BN2O4 (354.1750788)

N-(6-METHOXY-PYRIDIN-3-YL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

C19H23BN2O4 (354.1750788)

Piperazine-1-carboxamidine hemisulfate

C10H26N8O4S (354.17976360000006)

N-Benzyl-2-nitro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

C19H23BN2O4 (354.1750788)

1-octyl-2,3-dimethylimidazolium hexafluorophosphate

C13H25F6N2P (354.1659452)

1,3-DIPHENYL-4-ETHYL-5-(4-METHOXYPHENYL)-1H-PYRAZOLE

C24H22N2O (354.1732042)

3,7-Dioxa-4,6-disilanonane, 4,4,6,6-tetraethoxy-5-methyl-

C14H34O6Si2 (354.1893824)

3-Fluorophenyl 4-trans-butylcyclohexylbenzoate

C23H27FO2 (354.1994974)

1,8-bis(trimethoxysily)octane

C14H34O6Si2 (354.1893824)

Iclaprim

C19H22N4O3 (354.1691822)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EA - Trimethoprim and derivatives C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists C254 - Anti-Infective Agent > C258 - Antibiotic

4,4-bis-(2,3-Epoxypropoxy)-3,3,5,5-tetramethylbiphenyl

C22H26O4 (354.18309960000005)

1-(1-TRITYL-1H-IMIDAZOL-4-YL)ETHANOL

C24H22N2O (354.1732042)

1-hydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid

C22H26O4 (354.18309960000005)

Spermine-d8 tetrahydrochloride

C10H22Cl4D8N4 (354.172663424)

4,4,7,7-Tetraethoxy-3,8-dioxa-4,7-disiladecane

C14H34O6Si2 (354.1893824)

1,3,5(10),9(11)-Estratetrene-3,17β-diol diacetate

C22H26O4 (354.18309960000005)

Piperazine-1-carboxamidine 0.5-sulfate

C10H26N8O4S (354.17976360000006)

Benzyl (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate

C19H23BN2O4 (354.1750788)

TERT-BUTYL 4-AMINOSPIRO[CHROMAN-2,4-PIPERIDINE]-1-CARBOXYLATE HYDROCHLORIDE

C18H27ClN2O3 (354.17101019999996)

2-(1-trityl-1H-imidazol-4-yl)ethanol

C24H22N2O (354.1732042)

ETHYL 4-METHYL-2-(N-BOC-PIPERIDIN-4-YL)THIAZOL-5-YL CARBOXYLATE

C17H26N2O4S (354.16131960000007)

Estra-1,3,5(10),16-tetraene-3,17-diol diacetate

C22H26O4 (354.18309960000005)

BENZYL (5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)CARBAMATE

C19H23BN2O4 (354.1750788)

Zicronapine

C22H27ClN2 (354.18626520000004)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine

C17H22N8O (354.1916482)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1. VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.

5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine

C19H22N4O3 (354.1691822)

(S)-Iclaprim

C19H22N4O3 (354.1691822)

Isositsirikine

C21H26N2O3 (354.19433260000005)

vinca

C21H26N2O3 (354.19433260000005)

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids

4-(2-((2-Hydroxy-3-(1H-indol-4-yloxy)propyl)amino)-2-methylpropyl)phenol

C21H26N2O3 (354.19433260000005)

1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea

C19H22N4O3 (354.1691822)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

3-(3,5-Dimethyl-1-pyrazolyl)-6-[4-(4-fluorophenyl)-1-piperazinyl]-1,2,4,5-tetrazine

C17H19FN8 (354.1716626)

4-(9H-fluoren-9-yl)-N-(4-pyridinylmethylene)-1-piperazinamine

C23H22N4 (354.1844372)

2-Hydroxy-3-(phosphonooxy)propyl laurate

C15H31O7P (354.1807306)

7-Amino-2-Tert-Butyl-4-{[2-(1h-Imidazol-4-Yl)ethyl]amino}pyrido[2,3-D]pyrimidine-6-Carboxamide

C17H22N8O (354.1916482)

(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide

C17H26N2O4S (354.16131960000007)

Seratrodast

C22H26O4 (354.18309960000005)

Corynine

InChI=1\C21H26N2O3\c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24\h2-5,12,15,17-19,22,24H,6-11H2,1H3\t12?,15?,17?,18-,19+\m0\s

C21H26N2O3 (354.19433260000005)

G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2] Yohimbine is a potent and relatively nonselective alpha 2-adrenergic receptor (AR) antagonist, with IC50 of 0.6 μM. IC50 value: 0.6 uM [1] Target: alpha 2-adrenergic receptor in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3] in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]

Panicein F2

C22H26O4 (354.18309960000005)

Stemmadenin

15alpha-Stemmadenine

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid with formula C21H26N2O3, isolated from several plant species including Rhazya stricta, Tabernaemontana dichotoma and Aspidosperma pyricollum.

methyl (2R)-2-[(2R,3Z,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate

C21H26N2O3 (354.19433260000005)

Acetylnorajmaline

C21H26N2O3 (354.19433260000005)

(1E,2E,4E)-1-[5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,6-dimethylocta-2,4-dien-1-olate

C21H24NO4- (354.17052440000003)

6-[(E)-2-[2-(4-fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one

C22H23FO3 (354.16311399999995)

7-(2,5-Dihydroxy-3,4,6-trimethylphenyl)-7-phenylhept-6-enoic acid

C22H26O4 (354.18309960000005)

Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate

C17H26N2O6 (354.1790776)

[3-carboxy-2-[(2E,5E,7E)-10-carboxydeca-2,5,7-trienoyl]oxypropyl]-trimethylazanium

C18H28NO6+ (354.19165280000004)

[3-carboxy-2-[(4E,6E,8E)-10-carboxydeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium

C18H28NO6+ (354.19165280000004)

[3-carboxy-2-[(5E,7E,9E)-10-carboxydeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium

C18H28NO6+ (354.19165280000004)

[3-carboxy-2-[(3E,6E,9E)-10-carboxydeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium

C18H28NO6+ (354.19165280000004)

Epivincamine

C21H26N2O3 (354.19433260000005)

7-Benzyl-1,3-dimethyl-8-piperazin-1-yl-3,7-dihydro-purine-2,6-dione

C18H22N6O2 (354.18041519999997)

20-Epitabernemontanine

C21H26N2O3 (354.19433260000005)

Ala-Ala-Pro-Pro

C16H26N4O5 (354.19031060000003)

A tetrapeptide composed of two L-alanine units joined to two L-proline units by peptide linkages.

(1S,15R,18S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester

C21H26N2O3 (354.19433260000005)

(1S,15R,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester

C21H26N2O3 (354.19433260000005)

(-)-Minovincinine

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid that is (-)-vincadifformine which carries a hydroxy group at position 19R. A natural product found in several plant species including Catharanthus roseus and Vinca minor.

N-hydroxy-N-[(E)-(4-pyridin-2-ylphenyl)methylideneamino]heptanediamide

C19H22N4O3 (354.1691822)

N-hydroxy-N-[(E)-(4-pyridin-4-ylphenyl)methylideneamino]heptanediamide

C19H22N4O3 (354.1691822)

N-hydroxy-N-[(E)-(4-pyridin-3-ylphenyl)methylideneamino]heptanediamide

C19H22N4O3 (354.1691822)

1-(4-methoxyphenyl)-N-[2-(4-morpholinyl)ethyl]-4-pyrazolo[3,4-d]pyrimidinamine

C18H22N6O2 (354.18041519999997)

N-[2-[4-(dimethylamino)phenyl]-4-oxo-1,2-dihydroquinazolin-3-yl]carbamic acid ethyl ester

C19H22N4O3 (354.1691822)

1-(2,4-Diphenyl-2,3-dihydro-1,5-benzodiazepin-1-yl)propan-1-one

C24H22N2O (354.1732042)

(S)-cis-N-Methylcanadine

C21H24NO4+ (354.17052440000003)

His-Ala-Gln

C14H22N6O5 (354.1651602)

1-[(2R,3R)-1-[(2-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone

C21H23FN2O2 (354.17434699999995)

1-[(2S,3R)-1-[(2-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone

C21H23FN2O2 (354.17434699999995)

1-[(2S,3S)-1-[(2-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone

C21H23FN2O2 (354.17434699999995)

(S)-trans-N-methylcanadine

C21H24NO4+ (354.17052440000003)

Gln-Ala-His

C14H22N6O5 (354.1651602)

Ala-Gln-His

C14H22N6O5 (354.1651602)

Gln-His-Ala

C14H22N6O5 (354.1651602)

Ala-His-Gln

C14H22N6O5 (354.1651602)

His-Gln-Ala

C14H22N6O5 (354.1651602)

(1R,15R,18S,19R,20R)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester

C21H26N2O3 (354.19433260000005)

[(1R,9R,10S,12R,13S,14R,16S,18R)-13-ethyl-14-hydroxy-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-yl] acetate

C21H26N2O3 (354.19433260000005)

Propyl 2,7,7-trimethyl-5-oxo-4-pyridin-3-yl-3,4,6,8-tetrahydroquinoline-3-carboxylate

C21H26N2O3 (354.19433260000005)

Methyl (2beta,3beta,5alpha,12beta,19alpha)-3-hydroxy-6,7-didehydroaspidospermidine-3-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (1S,14S,15S)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (1S,11S,17R,18R)-18-[(1R)-1-methoxyethyl]-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate

C21H26N2O3 (354.19433260000005)

Tetra(N-butyl)-1,2-dichlorodisilane

C16H36Cl2Si2 (354.17324759999997)

Tert-butyldifluorotris(trimethylsilyl)methylsilane

C14H36F2Si4 (354.186204)

methyl (1S,9S,12R,16S,18R,21R)-12-oxido-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate

C21H26N2O3 (354.19433260000005)

1-Pentamethyldisilanyloxy-4-pentamethyldisilanylbenzene

C16H34OSi4 (354.1686634)

(7Z)-7-ethylidene-1-methoxy-5-methylspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3-indole]-2-one

C21H26N2O3 (354.19433260000005)

(S)-N-Methylcanadine

C21H24NO4+ (354.17052440000003)

1-lauroyl-sn-glycerol 3-phosphate

C15H31O7P (354.1807306)

A 1-acyl-sn-glycerol 3-phosphate having lauroyl (dodecanoyl) as the 1-O-acyl group.

16R,19E-isositsirikine

C21H26N2O3 (354.19433260000005)

A natural product found in Alstonia spatulata.

16-epivincamine

C21H26N2O3 (354.19433260000005)

A natural product found in Alstonia spatulata.

19S-hydroxy-(+)-vincadifformine

C21H26N2O3 (354.19433260000005)

(3R)-3-hydroxy-2,3-dihydrotabersonine

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid obtained by formal hydration across the 2,3-double bond of tabersonine.

(+)-Minovincinine

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid that is (+)-vincadifformine which carries a hydroxy group at position 19S. A natural product found in several plant species including Alstonia venenata and Catharanthus trichophyllus.

(1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester

C21H26N2O3 (354.19433260000005)

15beta-stemmadenine

C21H26N2O3 (354.19433260000005)

A monoterpenoid indole alkaloid with forumula C21H26N2O3, isolated from the fruits of Tabernaemontana heyneana.

LSM-18556

C21H26N2O3 (354.19433260000005)

LPEth 10:0

C15H31O7P (354.1807306)

LPM 11:0

C15H31O7P (354.1807306)

ST 18:2;O7

C18H26O7 (354.16784459999997)

ST 19:1;O;S

C19H30O4S (354.18647000000004)

ST 22:6;O4

C22H26O4 (354.18309960000005)

JZP-430

C16H26N4O3S (354.1725526)

JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL)[1].

7-chloro-6,9a-dimethyl-6-(4-methylpent-3-en-1-yl)-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-1,9-diol

C20H31ClO3 (354.1961606)

7'-ethylidene-1-methoxy-5'-methyl-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one

C21H26N2O3 (354.19433260000005)

methyl 15-ethyl-13-(hydroxymethyl)-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2,4,6,8-tetraene-13-carboxylate

C21H26N2O3 (354.19433260000005)

1-{20-hydroxy-16-methyl-15-oxa-1,11-diazahexacyclo[15.3.1.0⁴,¹².0⁴,²⁰.0⁵,¹⁰.0¹³,¹⁸]henicosa-5,7,9-trien-11-yl}ethanone

C21H26N2O3 (354.19433260000005)

(1r,9s,10s,12r,13z,18r)-13-ethylidene-18-(methoxycarbonyl)-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-trien-15-ium-15-olate

C21H26N2O3 (354.19433260000005)

(2s,4s)-5,7-dimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-ol

C22H26O4 (354.18309960000005)

14-(chloromethyl)-13,14-dihydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde

C20H31ClO3 (354.1961606)

methyl 2-{6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl}prop-2-enoate

C21H26N2O3 (354.19433260000005)

methyl 15-hydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (16e)-16-ethylidene-2-(hydroxymethyl)-4,14-diazatetracyclo[12.2.2.0³,¹¹.0⁵,¹⁰]octadeca-3(11),5,7,9-tetraene-2-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (13e)-13-ethylidene-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (1s,14s,15s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C21H26N2O3 (354.19433260000005)

cannabinolic acid a

C22H26O4 (354.18309960000005)

methyl 17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C21H26N2O3 (354.19433260000005)

(1s,4s,5r,9s,10r,13s,14s)-14-(chloromethyl)-13,14-dihydroxy-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde

C20H31ClO3 (354.1961606)

methyl (1s,11s,17r,18s)-18-[(1r)-1-methoxyethyl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (1s,14s,15s,18r)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C21H26N2O3 (354.19433260000005)

(2z)-2-[(5s,7r,9s)-14-hydroxy-9-methoxy-4-methyl-4,10-diazatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-1(17),11,13,15-tetraen-7-yl]but-2-enal

C21H26N2O3 (354.19433260000005)

methyl (3r,7r,8s)-7-ethyl-5-methyl-10-oxo-5,12-diazatetracyclo[9.7.0.0³,⁸.0¹³,¹⁸]octadeca-1(11),13,15,17-tetraene-3-carboxylate

C21H26N2O3 (354.19433260000005)

methyl (1s,17r,18s)-17-(2-hydroxyethyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C21H26N2O3 (354.19433260000005)

(1r,5s,6s)-3-(hydroxymethyl)-6-isopropyl-2-oxo-5-(propanoyloxy)cyclohex-3-en-1-yl (2e)-4-hydroxy-2-methylbut-2-enoate

C18H26O7 (354.16784459999997)

1-[12-(2-hydroxyethylidene)-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-8-yl]ethanone

C21H26N2O3 (354.19433260000005)

(1'r,2's,3s,4's,7's,9'r)-1,9'-dimethyl-2'-(2-oxopropyl)-10'-oxa-8'-azaspiro[indole-3,5'-tricyclo[5.4.0.0⁴,⁸]undecan]-2-one

C21H26N2O3 (354.19433260000005)

(2r)-2-{2-[3-(hydroxymethyl)-4-methoxy-2,6-dimethylphenyl]ethyl}-2-methylchromen-6-ol

C22H26O4 (354.18309960000005)

methyl (3as,4r,7ar)-4-{[(2s)-1-methoxy-1-oxopropan-2-yl]oxy}-3a,4,5,7a-tetrahydrospiro[1,3-benzodioxole-2,1'-cyclohexane]-6-carboxylate

C18H26O7 (354.16784459999997)

methyl 2-[(3r,6'r,7'r,8'ar)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]prop-2-enoate

C21H26N2O3 (354.19433260000005)

methyl (2e)-3-methoxy-2-{3-methyl-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}prop-2-enoate

C21H26N2O3 (354.19433260000005)

7-(1-chloro-2-hydroxyethyl)-2-hydroxy-1,4b,7,10a-tetramethyl-4,4a,5,6,8,8a,9,10-octahydrophenanthren-3-one

C20H31ClO3 (354.1961606)

methyl 18-(1-methoxyethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate

C21H26N2O3 (354.19433260000005)

[(1s,9s,10s,11r,12z,17s)-12-(2-hydroxyethylidene)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-10-yl]methyl acetate

C21H26N2O3 (354.19433260000005)

1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methyl-1-oxopent-3-en-2-yl acetate

C22H26O4 (354.18309960000005)

10-hydroxycoronaridine

C21H26N2O3 (354.19433260000005)

{"Ingredient_id": "HBIN000140","Ingredient_name": "10-hydroxycoronaridine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)O)C(=O)OC","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "14211;14212","PubChem_id": "52948159","DrugBank_id": "NA"}

11-hydroxycoronaridine

C21H26N2O3 (354.19433260000005)

{"Ingredient_id": "HBIN000441","Ingredient_name": "11-hydroxycoronaridine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)O)C(=O)OC","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "15834","PubChem_id": "44566751","DrugBank_id": "NA"}

15α-hydroxykopsinine

C21H26N2O3 (354.19433260000005)

{"Ingredient_id": "HBIN001613","Ingredient_name": "15\u03b1-hydroxykopsinine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "COC(=O)C1CC23CCCN4C2C5(C1(CC3O)NC6=CC=CC=C65)CC4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10292","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

17-chloro-13,16β-dihydroxy-ent-kauran-19-al

C20H31ClO3 (354.1961606)

{"Ingredient_id": "HBIN002010","Ingredient_name": "17-chloro-13,16\u03b2-dihydroxy-ent-kauran-19-al","Alias": "NA","Ingredient_formula": "C20H31ClO3","Ingredient_Smile": "CC1(CCCC2(C1CCC34C2CCC(C3)(C(C4)(CCl)O)O)C)C=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3548","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

19-heyneanine

C21H26N2O3 (354.19433260000005)

{"Ingredient_id": "HBIN002189","Ingredient_name": "19-heyneanine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36126","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

beta-yohimbine

C21H26N2O3 (354.19433260000005)

{"Ingredient_id": "HBIN018355","Ingredient_name": "beta-yohimbine","Alias": "NA","Ingredient_formula": "C21H26N2O3","Ingredient_Smile": "COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6233","PubChem_id": "5458418","DrugBank_id": "NA"}